Hollow-fiber reactors containing mammalian arginase: an approach to enzyme replacement therapy.
暂无分享,去创建一个
[1] J. Selkon,et al. β-LACTAMASE-PRODUCING ANÆROBES , 1980, The Lancet.
[2] A. De Flora,et al. In vitro correction of erythrocyte glucose 6-phosphate dehydrogenase (G6PD) deficiency. , 1979, Archives of biochemistry and biophysics.
[3] S. Brusilow,et al. NEW PATHWAYS OF NITROGEN EXCRETION IN INBORN ERRORS OF UREA SYNTHESIS , 1979, The Lancet.
[4] S. Cederbaum,et al. Hyperargininemia with Arginase Deficiency , 1979, Pediatric Research.
[5] G. Gregoriadis,et al. Enzyme therapy in genetic diseases , 1979, Nature.
[6] A. Beaudet,et al. Arginase deficiency in multiple tissues in argininemia , 1978, Clinical genetics.
[7] R. Stern,et al. RESTORATION OF IN-VITRO LYMPHOCYTE RESPONSES WITH EXOGENOUS ADENOSINE DEAMINASE IN A PATIENT WITH SEVERE COMBINED IMMUNODEFICIENCY , 1975, The Lancet.
[8] F. Vielle-Breitburd,et al. Rabbit liver L-arginase. Purification, properties, and subunit structure. , 1972, The Journal of biological chemistry.
[9] D. M. Greenberg,et al. Nuclear magnetic resonance studies of manganese binding of rat liver arginase. , 1971, The Journal of biological chemistry.
[10] A. Lowenthal,et al. ARGININÆMIA WITH ARGINASE DEFICIENCY , 1969 .
[11] R. Schimke,et al. THE IMPORTANCE OF BOTH SYNTHESIS AND DEGRADATION IN THE CONTROL OF ARGINASE LEVELS IN RAT LIVER. , 1964, The Journal of biological chemistry.